Bristol Myers: presentations scheduled at ESC Congress

Published: 2025-08-25 08:09:42 ET BMY

Published on 08/25/2025 at 08:09 am EDT

Bristol Myers Squibb says that new clinical and real-world data from its cardiovascular portfolio will be presented at the European Society of Cardiology (ESC) Congress, which will be held August 29-September 1 in Madrid.An oral presentation will show real-world results of Camzyos as a treatment for symptomatic obstructive hypertrophic cardiomyopathy (oHCM), according to COLLIGO-HCM, a global observational study reflecting diverse patient populations.Another oral presentation will highlight the efficacy and safety of Camzyos as monotherapy in the treatment of patients with oHCM, based on a pooled analysis of four Phase 3 studies.Finally, a last-minute oral presentation is scheduled to highlight the key results of ODYSSEY-HCM, a Phase 3 trial conducted in symptomatic NYHA Class II-III non-obstructive hypertrophic cardiomyopathy.